MedTrace Logo

Genetic Testing in Primary Congenital Glaucoma Patients

NCT01136460 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2014-09-18

No results posted yet for this study

Summary

Primary congenital glaucoma patients and their immediate relatives will undergo complete ophthalmic examination and an interview with a geneticist. A blood sample will be drown from all participants for DNA analysis.

The CYP1B1 gene coding sequences will be screened for all individuals. If no mutation or only one heterozygous mutation will be found in the CYP1B1 gene, screening for MYOC gene mutations will be performed.

Conditions

  • Congenital Glaucoma

Sponsors & Collaborators

  • Carmel Medical Center

    lead OTHER

Principal Investigators

  • Orna Geyer, Professor · Carmel Medical Center

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-05-31
Primary Completion
2020-05-31
Completion
2020-05-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01136460 on ClinicalTrials.gov